Merck has appointed George Addona as SVP and head of discovery, preclinical and translational medicine at Merck Research Laboratories.

Addona originally joined Merck in 2008 and has held various roles at the company, including VP of quantitative biosciences. He has also led development programs throughout cardio-metabolic, infectious disease, neuroscience and oncology. Prior to his Merck tenure, Addona held roles at Novartis and Praecis Pharmaceuticals.